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Conc~/on- More pa in ts  ~ severe lelt veofncu~ have 
been aemmpeed wdh ~ m rece~ years. Tha hosp~ ou~-ome is 
moeasm~y more ~ .  Loc~:J lemt o~',.~,-~e needs to be e.v-a k.~a~L,d o~e.r 
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Adpmct~ treatment ol PTCA w~h ar.,,:.,.~,T, ab ~s a. ,~x~t~l w~th 
reductmns m early ,.,~w~ts. but the effects of p~atelat GP Ig~lla receplm" 
antagon~ Iberapy on ~mcal res len~s,  as detirmd by lato ta+,get vessel 
mvasculanzation (TVR), remains uncorlam as conflfcZmg ~ hame 
I~=e~ reached in recent n~dlJ~efstor t iala+ We souQt~t to ~ W4,XEH~Ier 
the striking re~ucti~t m perq~0cedural MI afforded by ab~L, mT~tb ~ con- 
found an accumle assessment ol the drug's effects on the need for lato TVR 
In the I~lCebO-CO~tro~ed EPIC toal. 2.099 patients wilh high-rrsk ~ or 
an~0graph¢ features underwent PTCA or alberecfomy and were ~,+o~:,¢-,:.- 
~.ely followed for 3 yearn. Within ~ study pol~dalm¢~. I ~  CK 
e levat~ was a sKj.ificant predictor of late modalily. Among patients w~n 
elevated CK, however, a paradoxical decrease in the need for late TVR 
was present. This relationship became ~ l y  mere profound as the 
megn i~ of CK release increased+ 
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in+hol4t~al ~ MI, or a~hem~ Pnma~ FrC.,A was I~ffomted m 9116 
pa l~,  of whom 1.9",. had mMI and 10Ji% had ~ ~ e~ly ee~ 
la~ o~ ~ o~ mMI was m~l  mt~a~s ~30% or ~ we#eece ota 
TIMI Ik.w+ am+ ~',,T.-,--4X+S 7~te  were not pmdtct~m, 
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T~'efo~. opma~ m~eq~aaon appea~ to be supe~ fo corn ~a 
ana~y~ m pred¢-mg .~ho~d nacunent acbe~a or .m~fameon. Whee~ 
mm is clue to use ol gonmscopc findings ~ch  were nm mcomed on cme, 
acu~ usa of d,g*la~ m~0m~ or gmat~ ~r ' ,~r  e.,¢meeece desemam fu~her 
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Backgrmm~ We have immm~my dem,.,m+,,,~ed m-vain that mhefmckmmc 
(ATI-q aJrtsnal trireme +,,~, sour¢l as it expanencas meclwnmal dmmlmon. 
Me~floo~: TO fodl~r cbaraclenze acoustic + v ~  (AE) pmllems and 
to ~;y  tf AlE occur m-v~vo at the ~e of begoon a n ~  (BA), 24 
human atonal speomens oblamed post-mort~ and 8 ATH asd conlrel at. 
tenes m~wNo (n~zJswme) were evaluated Artones were ~ lo BA wflh 
s,~naneous moo ing  o( AlE usn~ a ~ i~=eele¢l~ ~a,~- 
dm+-e+. The recorded +~,-,~Is were m-~ized m IM Imme domain using we.,mCet 
teG-.-,Cmes and m lhe frequency domain using Fourier t,~+%-,~p+as, and
chamctmzzed a,~:,+~G.-~j m tbe t~e of ,~_ _,c~J trauma using K,+,~.+,-.+,+ neural 
rmtwork ~ 
P.est.dls: Vascular AIE were demormtraled to occur be;-,~,m~,-+ 30 and 5000 
Hz+ Umng q~m:trograms wilh Koh+.-,~ dasmfmaZton, lhe sounds were char- 
aclenzed as no~eeless, plaque Iraclzae aml lasrlng. The io-vwo dala i+~¢afe 
fewer ex1~-,~us r:,~,~-,as nd 1ha same AE ~ as ,~-~-,~d in ff~e + 
v~ro s~dms. Tean.g m ~ w~ rela1~ely Ion9 (0.4-1,0S) ~;~r+'  
AE. pagoo~ opor,ng with shoder and lower frequency AE. and frectum wi1~ 
even sha,ler (0.1 s) and "c~per' AE 
Conctus~n: We have demonstrated mat vascular ecous~ emtssk~ 
eccur fogo~ng amemma mjury bom m-vitro and m-~vo. Wavefo~n ar~/m 
helps to ~ r  dL~bngutsh normal from pat t~ vascular iojury. ~ data 
supparl the ~- ,c~ of ush'Kj a¢ous~ em=sions as a meens of mor~ortng 
and optin'nzing balloon anojol~asty 
Mechanistically. while it is unlikely that CK elevation prevents vascular 
renanowing per se. myocardial necrosis impairs the clinical manifestation of 
restenosis, thereby reducing the need for ischemia-driven "l V'R. 
Conclusion: In the EPIC study, patients with pariprocedural MI were less 
likely to develop clinical restenosis as measured by the need for TVR at 3 
years. This novel finding (1) highlights a mechanism for potential discordance 
between anglographic and clinical measures of restenosis, and (2) has im- 
plications for future clinical trials, as therapies which reduce periprocedurat 
MI may be associated wit,1 a perceived excess of restenosis when moasured 
by the need for TVR+ 
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